Angela Crowley, MD
Rheumatology · Willowbrook, ILNPI 1205978475
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Amgen at 25.3% of the total. Among rheumatology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,325 payments — averaging $364.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$122K
- Johnson & Johnson$95K
- AbbVie$70K
- GSK$47K
- Kyowa Kirin, Inc.$45K
- UCB, Inc.$37K
- plus $67K from 26 others
Across 260 payments — averaging $26,918 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$5.3M
- Novartis$704K
- AbbVie$396K
- Eli Lilly$245K
- Janssen Research & Development, LLC$193K
- UCB SA$86K
- plus $84K from 3 others
What the payments were for
- Consulting fees$126,92026%
- Speaking & faculty fees$282,42659%
- Travel & lodging$40,4388%
- Food & beverage$32,4467%
- Education$4260%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 289 | $122,180 |
| Johnson & Johnson | 174 | $94,880 |
| AbbVie | 276 | $69,626 |
| GSK | 47 | $46,838 |
| Kyowa Kirin, Inc. | 73 | $45,226 |
| UCB, Inc. | 95 | $37,144 |
| Novartis | 81 | $27,505 |
| AstraZeneca(2 entities) | 59 | $20,846 |
| Janssen Scientific Affairs, LLC | 15 | $8,601 |
| Sobi, Inc | 3 | $3,201 |
| UCB SA | 2 | $1,380 |
| Pfizer | 55 | $1,278 |
| Lilly USA, LLC | 52 | $1,122 |
| Radius Health, Inc. | 23 | $512 |
| Sanofi | 11 | $334 |
| E.r. Squibb & Sons, L.L.C. | 13 | $319 |
| Genentech USA, Inc. | 16 | $283 |
| Argenx US, Inc. | 4 | $245 |
| Boehringer Ingelheim | 10 | $237 |
| Bristol Myers Squibb | 3 | $177 |
| Novo Nordisk | 3 | $143 |
| Fresenius Kabi USA, LLC | 4 | $115 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Aurinia Pharma U.S., Inc. | 4 | $88 |
| Mallinckrodt Hospital Products Inc. | 3 | $71 |
| ANI Pharmaceuticals, Inc. | 2 | $49 |
| Invivyd Inc | 2 | $41 |
| Organon | 1 | $31 |
| Almatica Pharma LLC | 1 | $28 |
| Tonix Medicines, Inc. | 1 | $24 |
| Abbott | 1 | $16 |
| Antares Pharma, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$482,656 in reported general payments places this provider in the 95th percentile of 287 rheumatology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 194 | $7,586 |
| MethotrexateMethotrexate Sodium | 204 | $6,524 |
| Febuxostat | 33 | $3,876 |
| Colchicine | 44 | $3,210 |
| Mycophenolate Mofetil | 32 | $3,140 |
| Leflunomide | 40 | $2,704 |
| Azathioprine | 26 | $1,623 |
| Prednisone | 231 | $1,566 |
| Celecoxib | 39 | $1,287 |
| Allopurinol | 90 | $902 |
| Gabapentin | 65 | $701 |
| Duloxetine Hcl | 50 | $644 |
| Methylprednisolone | 46 | $240 |
| Meloxicam | 33 | $204 |
| Alendronate Sodium | 25 | $197 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Willowbrook
- Manish JainChicago$1.9M
- Lori SiegelBannockburn$1.5M
- Alfonso BelloGlenview$611K
- Theodore PincusChicago$524K
- Eric RudermanChicago$440K
- Anisha DuaChicago$280K
- Arthur MandelinChicago$270K
- Jeffrey HorvathSpringfield$246K
- Robert HozmanSkokie$152K
- Robert WoodrickChicago$143K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.